In HCC, POSTN-deficient mice showed reduced diethylnitrosamine-induced liver cancer [18], while POSTN expression in hepatocellular carcinoma was associated with a poor prognosis in human patients [19,20]. This evidence concerns the gene POSTN and hepatocellular carcinoma.